The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients
Extracellular vesicles (EVs) are membrane-bound particles involved in intercellular communication. They carry proteins, lipids, and nucleotides such as microRNAs (miRNAs) from the secreting cell that can modulate target cells. We and others have previously described the presence of EVs in peripheral...
Main Authors: | Matías Sáenz-Cuesta, Ainhoa Alberro, Maider Muñoz-Culla, Iñaki Osorio-Querejeta, Marta Fernandez-Mercado, Itziar Lopetegui, Mikel Tainta, Álvaro Prada, Tamara Castillo-Triviño, Juan Manuel Falcón-Pérez, Javier Olascoaga, David Otaegui |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/8/2448 |
Similar Items
-
Therapeutic Potential of Extracellular Vesicles for Demyelinating Diseases; Challenges and Opportunities
by: Iñaki Osorio-Querejeta, et al.
Published: (2018-11-01) -
Fingolimod in children with Rett syndrome: the FINGORETT study
by: Yvonne Naegelin, et al.
Published: (2021-01-01) -
Safety of generic fingolimod
by: O. M. Koval, et al.
Published: (2018-03-01) -
Effect of fingolimod on platelet count among multiple sclerosis patients
by: Mehrdad Farrokhi, et al.
Published: (2015-01-01) -
Weight Loss and Fingolimod
by: Nefati Kıylıoğlu
Published: (2017-12-01)